These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 38379319
1. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy. Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y. Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319 [Abstract] [Full Text] [Related]
2. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM. BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996 [Abstract] [Full Text] [Related]
3. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy. Li S, Hao H, Li R, Guo S. Tohoku J Exp Med; 2022 Mar 15; 256(3):215-223. PubMed ID: 35314529 [Abstract] [Full Text] [Related]
4. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy. Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY. Front Immunol; 2024 Mar 15; 15():1326026. PubMed ID: 38426107 [Abstract] [Full Text] [Related]
5. Differential expression of urinary exosomal microRNAs in IgA nephropathy. Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ. J Clin Lab Anal; 2018 Feb 15; 32(2):. PubMed ID: 28383146 [Abstract] [Full Text] [Related]
6. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy. Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L. Nephron; 2019 Feb 15; 142(3):195-207. PubMed ID: 30808829 [Abstract] [Full Text] [Related]
7. Urinary miRNA profile for the diagnosis of IgA nephropathy. Szeto CC, Wang G, Ng JK, Kwan BC, Mac-Moune Lai F, Chow KM, Luk CC, Lai KB, Li PK. BMC Nephrol; 2019 Mar 04; 20(1):77. PubMed ID: 30832601 [Abstract] [Full Text] [Related]
8. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy. Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY. Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445 [Abstract] [Full Text] [Related]
9. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy. Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V. Int Urol Nephrol; 2023 Jun 13; 55(6):1557-1564. PubMed ID: 36648741 [Abstract] [Full Text] [Related]
10. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease. Szeto CC, Ng JK, Fung WW, Chan GC, Luk CC, Lai KB, Wang G, Chow KM, Mac-Moune Lai F. Clin Chim Acta; 2022 May 01; 530():81-86. PubMed ID: 35278407 [Abstract] [Full Text] [Related]
11. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy. Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC. Am J Pathol; 2018 Nov 01; 188(11):2542-2552. PubMed ID: 30142333 [Abstract] [Full Text] [Related]
12. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy. Zhao S, Sun Y, Mao Q, Zhou C, Chen Y, Xue D. Nephron; 2022 Nov 01; 146(6):539-552. PubMed ID: 35381590 [Abstract] [Full Text] [Related]
13. Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathy. Pawluczyk IZA, Soares MSF, Barratt WA, Brown JR, Bhachu JS, Selvaskandan H, Zeng Y, Sarania R, Molyneux K, Roberts ISD, Barratt J. Nephrol Dial Transplant; 2020 Nov 01; 35(11):1865-1877. PubMed ID: 32830258 [Abstract] [Full Text] [Related]
14. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L, Cai K, Wang K, Luo Q. J Clin Lab Anal; 2021 Jun 01; 35(6):e23774. PubMed ID: 33951240 [Abstract] [Full Text] [Related]
15. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy. Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H. Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814 [Abstract] [Full Text] [Related]
16. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy. Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM. Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966 [Abstract] [Full Text] [Related]
17. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. Li G, Wu W, Zhang X, Huang Y, Wen Y, Li X, Gao R. BMC Nephrol; 2018 Nov 14; 19(1):326. PubMed ID: 30428849 [Abstract] [Full Text] [Related]
18. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. Guan J, Wang M, Zhao M, Ni W, Zhang M. BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570 [Abstract] [Full Text] [Related]
19. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy. Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K. Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628 [Abstract] [Full Text] [Related]
20. Clinical and pathological correlation between urinary exosome miR-223 and IgAN patients. Song J, Qin X, Li H, Huang G, Bi H. Clin Nephrol; 2023 Nov 11; 100(5):209-215. PubMed ID: 37622669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]